about
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-AtherosclerosisArginase promotes endothelial dysfunction and hypertension in obese ratsArginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase functionArginase inhibition attenuates arteriogenesis and interferes with M2 macrophage accumulation.KLK1 and ZG16B proteins and arginine-proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery.Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs.Arginase: an old enzyme with new tricks.Arginase Inhibitors: A Rational Approach Over One Century.Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique.Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs.Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.Arginase in the vascular endothelium: friend or foe?Arginase and α-smooth muscle actin induction after hyperoxic exposure in a mouse model of bronchopulmonary dysplasia.Polyamine concentration is increased in thoracic ascending aorta of patients with bicuspid aortic valve.Pulmonary arterial hypertension in rats due to age-related arginase activation in intermittent hypoxia.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats.Plasmatic Concentrations of ADMA and Homocystein in Llama (Lama glama) and Regulation of Arginase Type II: An Animal Resistent to the Development of Pulmonary Hypertension Induced by Hypoxia.Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
P2860
Q26991946-31F4FC30-44C0-44E9-BF87-1EA8754845D5Q28386943-92EC3A63-BE23-49CB-8A56-5EBAF68411DCQ34730537-D0EDEBAC-F630-4814-A475-FF00FB57A7E2Q35217395-DB51D822-5A05-43BB-B8EB-91DB9249506BQ36033820-849154F5-5C41-41CC-9CA5-2428EA887BE7Q36069848-001303AF-653B-4F8D-B93B-A52F356551D6Q36124220-B7B4E438-4077-4E7D-AD4D-B6B263C0DB5DQ36181367-996B1A09-D9E3-4DF2-AC2D-33C73DA6780FQ38452432-66F301B2-8939-4E12-BB77-5DDADC247890Q39012928-58334231-944A-4FBD-AC57-043FF514D9A5Q41558315-EB83E710-3E3A-4809-8C46-0ADC8CB35BAAQ41572196-562C9862-BEDD-4D9F-A211-03F6CF76801BQ41572947-10D3DE8B-4584-4E16-8B28-1791B599216FQ43007746-B2768115-C225-4800-A02D-1A3A730D7658Q47266163-FD105807-1C5C-4787-A0AE-26F46CB58CCDQ47392995-4B60E7BA-CE97-48C0-B601-698E12030E7EQ48009161-47E290CA-42BE-4480-B8F2-10BD2D215B15Q52665595-ADCFC0DE-270C-4773-8B31-71F84A9906E1Q53691008-476B395B-0E61-48C0-8ED7-57CBAD6204F0Q55008964-07C06EC9-5C7F-4F2C-B772-4458414AEF50Q55476883-3C5392C5-0336-497D-8AC4-E1CB80C68258
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Role of arginase in vessel wall remodeling.
@en
type
label
Role of arginase in vessel wall remodeling.
@en
prefLabel
Role of arginase in vessel wall remodeling.
@en
P2860
P356
P1476
Role of arginase in vessel wall remodeling.
@en
P2093
William Durante
P2860
P356
10.3389/FIMMU.2013.00111
P577
2013-05-13T00:00:00Z